43
Participants
Start Date
September 30, 2012
Primary Completion Date
July 31, 2015
Study Completion Date
July 31, 2015
BEZ235
BEZ235 will be supplied as 50mg, 100mg, 200mg, 300mg and 400mg SDS sachets. At each patient's visit, patient will reecive a prescription of an adequate drug supply for self administration at home.
BKM120
BKM120 will be supplied as 10mg and 50mg hard gelatin capsules. At each patient's visit, patient will reecive a prescription of an adequate drug supply for self administration at home.
BEZ235
BEZ235 will be supplied as 50mg, 100mg, 200mg, 300mg and 400mg SDS sachets. At each patient's visit, patient will reecive a prescription of an adequate drug supply for self administration at home.
BKM120
BKM120 will be supplied as 10mg and 50mg hard gelatin capsules. At each patient's visit, patient will reecive a prescription of an adequate drug supply for self administration at home.
Novartis Investigative Site, Wilrijk
Novartis Investigative Site, Marseille
Novartis Investigative Site, Madrid
Cedars Sinai Medical Center SC, Los Angeles
Novartis Investigative Site, Villejuif
Hackensack University Medical Center Hackensack Univ, Hackensack
Novartis Investigative Site, Brussels
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Barcelona
Novartis Investigative Site, Sutton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY